Michele E. Cameron

Michele E. Cameron serves as a Contract Officer at the Naval Medical Logistics Command (N62645), where she plays a pivotal role in securing critical medical logistics capabilities to sustain Navy and Marine Corps operational readiness. She manages the full lifecycle of acquisitions for high-priority medical equipment, diagnostic systems, and life-sustaining supplies, ensuring compliance with Defense Federal Acquisition Regulation Supplement (DFARS) and Federal Acquisition Regulation (FAR) requirements. Her portfolio emphasizes rapid-response procurements that support combat casualty care, point-of-care diagnostics, and preventive medicine infrastructure across global theaters, aligning directly with the Command’s mission to maintain a resilient, expeditionary medical logistics pipeline. While specific contractor names are not disclosed, Cameron routinely engages with a diverse pool of vendors, including large prime contractors with proven track records in medical device manufacturing and clinical supply chain management, as well as specialized small businesses capable of delivering niche diagnostic and laboratory services. Her contracting approach prioritizes performance-based acquisition strategies, requiring rigorous technical evaluations and lifecycle cost analyses to ensure mission-critical reliability under austere conditions. Cameron demonstrates a strong commitment to socioeconomic contracting, with approximately one-third of her awards structured as Total Small Business Set-Asides under FAR 19.5. She consistently prioritizes small business participation, particularly among firms certified as small businesses under SBA size standards, though no specific 8(a), HUBZone, or SDVOSB preferences are dominant in her portfolio. Her approach reflects a balanced focus on competition and capability, ensuring broad vendor access while maintaining mission-critical standards. Her primary procurement focus centers on NAICS 622110 (General Medical and Surgical Hospitals), reflecting demand for hospital-grade medical systems, and NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing), underscoring her expertise in acquiring advanced diagnostic reagents and point-of-care testing platforms. She also procures mental health services and clinical laboratory testing under NAICS 621330 and 541380, demonstrating technical fluency in both clinical operations and diagnostic science.